[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Bariatric Surgery Devices Market Size, Share & Trends Analysis Report By Procedures (Adjustable Gastric Band, Vertical Sleeve Gastrectomy, Roux-en-Y Gastric Bypass), And Segment Forecasts, 2012 - 2022

April 2018 | 80 pages | ID: B2D76B81DB7EN
Grand View Research, Inc.

US$ 5,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report can be delivered to the clients within 24 Business Hours

The global bariatric surgery devices market is expected to reach USD 2.8 billion by 2022, according to a new report by Grand View Research, Inc. The growing incidence rate of obesity has led to many government initiatives at regional as well as global level to increase the awareness related to obesity and undertake various incidence curbing action plans. For instance, the South Wales government launched the NSW Healthy Eating and Active Living Strategy 2013-2018 for preventing obesity.

In addition, to strategic planning, the governments of developed nations are also funding universities to design strategic interventions to control the rising obesity. For the year 2014, New Zealand invested USD 40 million for its Healthy Families NZ anti-obesity initiative. Moreover, industry players are also trying to tackle the rising problem of obesity by launching new products. In February 2017, a startup company, Allurion Technologies, located in Massachusetts, U.S. filed a regulatory filing to report the USD 19 million raised amount out of the target of USD 27 million. The funds were intended to use for the development non-endoscopic gastric balloon, Ellipse. This device is in the form of capsule which when swallowed, is inflated in the stomach and deflates after months and is passed out without the need for anesthesia for its removal. This device is anticipated to revolutionize the bariatric surgery devices market due to its ease of use over the forecast period

The demand for non-invasive surgeries is also increasing, as non-invasive surgeries save time, cost, and decrease hospital stay. Governments are also encouraging the use of more incisionless surgeries in order to decrease the cases of infection. For instance, in July 2015, the FDA approved a balloon device, where the balloon is directly swallowed using a sterile solution.

Further Key Findings from the Report Suggest:
  • Gastric bypass surgery dominated the market in 2014 due to its early adoption since 1960 and the fact that it is the combination of both restrictive and malabsorptive procedures.
  • The sleeve gastrectomy surgery is expected to witness rapid rise in demand owing to, the procedure's incision-less nature. The fact that the procedure does not involve re-routing the intestine is also likely to drive segment growth. With the FDA approval of ReShape balloon, there has been a recent FDA filing for Ellipse device, which is swallowed and gets excreted naturally after four months.
  • North America was the largest regional market owing to the presence of market players introducing innovative technologies to improve patient care.
  • Favorable government initiatives are also expected to play pivotal roles in the European market growth. For instance, the German Federal Ministry of Education and Research (BMBF) formed two funding research programs namely the Competence Network Obesity and Integrated Research and Treatment Center (IFB) Adiposity Diseases with budgets allocated at around USD 26 million for 2012-2015.
  • Asia Pacific followed North America in terms of obesity and overweight prevalence. This coupled with the presence of large untapped opportunities is expected to help the Asia Pacific bariatric surgery market register the fastest growth over the forecast period.
  • Some key players of this market include Covidien Plc, Intuitive Surgical Inc., TransEnterix Inc., Allergan Inc., USGI Medical Inc., Semiled Ltd., Cousin Biotech, GI Dynamics Inc., Johnson and Johnson and Mediflex Surgical Product.
CHAPTER 1. METHODOLOGY AND SCOPE

1.1. Research methodology
1.2. Research scope & assumption
1.3. List of data sources

CHAPTER 2. EXECUTIVE SUMMARY

2.1. Bariatric Surgery Market - Industry Summary and Key Buying Criteria, 2012 - 2022

CHAPTER 3. BARIATRIC SURGERY INDUSTRY OUTLOOK

3.1. Bariatric Surgery Market Segmentation
3.2. Bariatric Surgery Market Size And Growth Prospects
3.3. Bariatric Surgery Market Dynamics
  3.3.1. Market Driver Analysis
  3.3.2. Market Restraint Analysis
3.4. Key Opportunities Prioritized
3.5. Industry analysis - Porter's
3.6. Bariatric Surgery Market PESTEL Analysis, 2014

CHAPTER 4. BARIATRIC SURGERY PROCEDURES OUTLOOK

4.1. Bariatric Surgery Market Share by procedures, 2014 & 2022
4.2. Adjustable Gastric Band (AGB) Market Estimates And Forecasts, 2012 - 2022 (USD Million)
4.3. Vertical Sleeve Gastrectomy (VSG) Market Estimates And Forecasts, 2012 - 2022 (USD Million)
4.4. Roux-en-Y Gastric Bypass (RYGB) Market Estimates And Forecasts, 2012 - 2022 (USD Million)
4.5. Biliopancreatic Diversion with a Duodenal Switch (BPD-DS) Market Estimates And Forecasts, 2012 - 2022 (USD Million)
4.6. Others Market Estimates And Forecasts, 2012 - 2022 (USD Million)

CHAPTER 5. BARIATRIC SURGERY REGIONAL OUTLOOK

5.1. North America
  5.1.1. Bariatric Surgery Market Estimates And Forecasts, by Procedures, 2012 - 2022 (USD Million)
5.2. Europe
  5.2.1. Bariatric Surgery Market Estimates And Forecasts, by Procedures, 2012 - 2022 (USD Million)
5.3. Asia Pacific
  5.3.1. Bariatric Surgery Market Estimates And Forecasts, by Procedures, 2012 - 2022 (USD Million)
5.4. Latin America
  5.4.1. Bariatric Surgery Market Estimates And Forecasts, by Procedures, 2012 - 2022 (USD Million)
    5.4.1.1. Mexico market estimates and forecasts
    5.4.1.2. Brazil market estimates and forecasts
5.5. MEA
  5.5.1. Bariatric Surgery Market Estimates And Forecasts, by Procedures, 2012 - 2022 (USD Million)

CHAPTER 6. COMPETITIVE LANDSCAPE

6.1. Allergan Inc.
  6.1.1. Company Overview
  6.1.2. Financial Performance
  6.1.3. Procedures Benchmarking
  6.1.4. Strategic Initiatives
6.2. Covidien Plc
  6.2.1. Company Overview
  6.2.2. Financial Performance
  6.2.3. Procedures Benchmarking
  6.2.4. Strategic Initiatives
6.3. Johnson and Johnson Company Overview
  6.3.1. Financial Performance
  6.3.2. Procedures Benchmarking
  6.3.3. Strategic Initiatives
6.4. Intuitive Surgical Inc.
  6.4.1. Company Overview
  6.4.2. Financial Performance
  6.4.3. Procedures Benchmarking
  6.4.4. Strategic Initiatives
6.5. GI Dynamics Inc.
  6.5.1. Company Overview
  6.5.2. Financial Performance
  6.5.3. Procedures Benchmarking
  6.5.4. Strategic Initiatives
6.6. TransEnterix Inc.
  6.6.1. Company Overview
  6.6.2. Financial Performance
  6.6.3. Procedures Benchmarking
  6.6.4. Strategic Initiatives
6.7. USGI Medical Inc.
  6.7.1. Company Overview
  6.7.2. Financial Performance
  6.7.3. Procedures Benchmarking
  6.7.4. Strategic Initiatives
6.8. SemiLEDs Ltd.
  6.8.1. Company Overview
  6.8.2. Financial Performance
  6.8.3. Procedures Benchmarking
  6.8.4. Strategic Initiatives
6.9. Cousin Biotech
  6.9.1. Company Overview
  6.9.2. Financial Performance
  6.9.3. Procedures Benchmarking
  6.9.4. Strategic Initiatives
6.10. Mediflex Surgical Procedures.
  6.10.1. Company Overview
  6.10.2. Financial Performance
  6.10.3. Procedures Benchmarking
  6.10.4. Strategic Initiatives



LIST OF TABLES

&^%fb 1. BARIATRIC SURGERY MARKET - INDUSTRY SUMMARY & KEY BUYING CRITERIA, 2012 - 2022
&^%fb 2. BARIATRIC SURGERY MARKET, BY PROCEDURES, 2012 - 2022 (USD MILLION)
&^%fb 3. BARIATRIC SURGERY MARKET, BY REGION, 2012 - 2022 (USD MILLION)
&^%fb 4. BARIATRIC SURGERY MARKET - KEY MARKET DRIVERS ANALYSIS
&^%fb 5. BARIATRIC SURGERY MARKET - KEY MARKET RESTRAINTS ANALYSIS
&^%fb 6. NORTH AMERICA MARKET, BY PROCEDURES, 2012 - 2022 (USD MILLION)
&^%fb 7. U.S. AND CANADA MARKET, BY PROCEDURES, 2012 - 2022 (USD MILLION)
&^%fb 8. EUROPE MARKET, BY PROCEDURES, 2012 - 2022 (USD MILLION)
&^%fb 9. UK MARKET, BY PROCEDURES, 2012 - 2022 (USD MILLION)
&^%fb 10. FRANCE MARKET, BY PROCEDURES, 2012 - 2022 (USD MILLION)
&^%fb 11. GERMANY MARKET, BY PROCEDURES, 2012 - 2022 (USD MILLION)
&^%fb 12. ASIA PACIFIC MARKET, BY PROCEDURES, 2012 - 2022 (USD MILLION)
&^%fb 13. JAPAN MARKET, BY PROCEDURES, 2012 - 2022 (USD MILLION)
&^%fb 14. CHINA MARKET, BY PROCEDURES, 2012 - 2022 (USD MILLION)
&^%fb 15. INDIA MARKET, BY PROCEDURES, 2012 - 2022 (USD MILLION)
&^%fb 16. LATIN AMERICA MARKET, BY PROCEDURES, 2012 - 2022 (USD MILLION)
&^%fb 17. MEXICO MARKET, BY PROCEDURES, 2012 - 2022 (USD MILLION)
&^%fb 18. BRAZIL MARKET, BY PROCEDURES, 2012 - 2022 (USD MILLION)
&^%fb 19. MIDDLE EAST AND AFRICA (MEA) MARKET, BY PROCEDURES, 2012 - 2022 (USD MILLION)
&^%fb 20. SOUTH AFRICA MARKET, BY PROCEDURES, 2012 - 2022 (USD MILLION)

LIST OF FIGURES

&^%fb 1. BARIATRIC SURGERY MARKET SEGMENTATION
&^%fb 2. GLOBAL BARIATRIC SURGERY MARKET REVENUE, 2012 - 2022
&^%fb 3. BARIATRIC SURGERY MARKET DYNAMICS
&^%fb 4. KEY OPPORTUNITIES PRIORITIZED
&^%fb 5. BARIATRIC SURGERY MARKET ANALYSIS - PORTER'S
&^%fb 6. BARIATRIC SURGERY MARKET ANALYSIS - PESTEL ANALYSIS
&^%fb 7. GLOBAL BARIATRIC SURGERY MARKET BY PROCEDURES, 2012 - 2022 (USD MILLION)
&^%fb 8. ADJUSTABLE GASTRIC BAND (AGB) MARKET, 2012 - 2022 (USD MILLION)
&^%fb 9. VERTICAL SLEEVE GASTRECTOMY (VSG)MARKET, 2012 - 2022 (USD MILLION)
&^%fb 10. ROUX-EN-Y GASTRIC BYPASS (RYGB) MARKET, 2012 - 2022 (USD MILLION)
&^%fb 11. BILIOPANCREATIC DIVERSION WITH A DUODENAL SWITCH (BPD-DS) MARKET, 2012 - 2022 (USD MILLION)
&^%fb 12. GLOBAL BARIATRIC SURGERY MARKET, BY REGION 2012 TO 2022 (USD MILLION)
&^%fb 13. NORTH AMERICA MARKET, BY PROCEDURES, 2012 TO 2022 (USD MILLION)
&^%fb 14. U.S. AND CANADA MARKET, BY PROCEDURES, 2012 TO 2022 (USD MILLION)
&^%fb 15. EUROPE MARKET, BY PROCEDURES, 2012 TO 2022 (USD MILLION)
&^%fb 16. UK MARKET, BY PROCEDURES, 2012 TO 2022 (USD MILLION)
&^%fb 17. FRANCE MARKET, BY PROCEDURES, 2012 TO 2022 (USD MILLION)
&^%fb 18. GERMANY MARKET, BY PROCEDURES, 2012 TO 2022 (USD MILLION)
&^%fb 19. ASIA PACIFIC MARKET, BY PROCEDURES, 2012 TO 2022 (USD MILLION)
&^%fb 20. JAPAN MARKET, BY PROCEDURES, 2012 TO 2022 (USD MILLION)
&^%fb 21. CHINA MARKET, BY PROCEDURES, 2012 TO 2022 (USD MILLION)
&^%fb 22. INDIA MARKET, BY PROCEDURES, 2012 TO 2022 (USD MILLION)
&^%fb 23. LATIN AMERICA MARKET, BY PROCEDURES, 2012 TO 2022 (USD MILLION)
&^%fb 24. BRAZIL MARKET, BY PROCEDURES, 2012 TO 2022 (USD MILLION)
&^%fb 25. MEA MARKET, BY PROCEDURE, 2012 TO 2022 (USD MILLION)
&^%fb 26. SOUTH AFRICA MARKET, BY PROCEDURE, 2012 TO 2022 (USD MILLION)


More Publications